Opportunities for permanent roles in a range of business sectors

Oncology Study Physician

Company Description

Mundipharma is a global (ex-US) network of independent associated companies that research, develop and manufacture innovative pharmaceutical medicines and consumer healthcare products. We are an agile and fast-paced company seeking to increase access to health care through programmes and effective partnerships.

We are forward-looking and dedicated to bringing innovative treatments to many of the world’s most challenging conditions and diseases including: Pain Management & Supportive Care, Consumer Health, Anti-Infectives, Biosimilars, CNS, Diabetes, Oncology, Ophthalmology, Respiratory and transplantation immunity.

We make a difference to patient lives by delivering value to healthcare professionals in 120+ countries across Africa, Asia Pacific, Canada, Europe, Latin America, and the Middle East.

Our guiding principles, centred around Integrity and Patient-Centricity, are at the heart of everything we do. We encourage our people to think differently and our inclusive culture of continuous learning and collaboration make Mundipharma a great place to work.

 

Job Purpose

The Oncology study physician is responsible for leading day-to-day activities within Mundipharma and with study investigators to ensure the smooth and safe conduct of one or more Oncology clinical studies. This will ensure progression in development for Mundipharma Oncology assets and that clinical studies are conducted in a manner compliant with GCP.

Key Responsibilities

  1. As a subject matter expert in the area of Oncology / Haematology, provides clinical / medical input to study materials, results interpretation and publication, and advisory boards, as required.
  2. Provides Regulatory with clinical and scientific expertise, may coordinate and writes relevant sections of regulatory documentation and submissions (e.g. Investigator Brochures; Scientific Advice briefing documents etc., and provide responses to questions from regulatory authorities etc.)
  3. Represents Clinical R&D in meetings with Key Opinion Leaders and other external clinical experts e.g. Study investigators and other site personnel, and at Investigator meetings.
  4. Serves as Medical Monitor, responsible for the safety monitoring of clinical trials, and as medical specialist for Phase I-IV studies in oncology and haemato-oncology.
  5. Supports External R&D in the assessment of new early development opportunities: e.g. providing both initial assessments and full Due Diligence input to clinical evaluation.

Communication & Working Relationships

  1. Head of Clinical Development Oncology- Reporting line; daily communication on study progress, potential risks and emerging data
  2. Clinical Operations study teams- Day-to-day communication to discuss study operations
  3. Investigators- Frequent communication regarding patients on trial, patients in screening, overall study recruitment and results etc.

Working Conditions

Travel to conferences (1-2 per year) and to investigator sites within Europe (3-4 times per year)

Qualifications

Minimum Required

  • MD (or international equivalent for qualified physician)
  • Several years of post-registration clinical experience, preferably in Oncology / Haemato-Oncology
  • Clinical or research experience (in an academic, pharmaceutical or CRO environment) related to the design and/or conduct of clinical studies in oncology or haemato-oncology.

Preferred

  • Board certification (or equivalent) in Oncology or Haemato-oncology

Knowledge and Skills

  • Drug development and clinical research
  • Oncology and/or Haemato-Oncology
  • Knowledge of ICH GCP guidelines